John Paulson's MDGL Position Overview
John Paulson (via Paulson & Co. Inc.) currently holds 1.91 M shares of Madrigal Pharmaceuticals, Inc. (MDGL) worth $874.9 M, representing 29.46% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, John Paulson has maintained a strategic position in MDGL, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 669,259 shares. Largest reduction occurred in Q3 2025, reducing 182,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Paulson's Madrigal Pharmaceuticals (MDGL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Madrigal Pharmaceuticals (MDGL) Trades by John Paulson
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2023 | +350,200 | New Buy | 350,200 | $231.00 |
| Q3 2023 | +149,800 | Add 42.78% | 500,000 | $146.04 |
| Q4 2023 | +605,741 | Add 121.15% | 1.11 M | $231.38 |
| Q1 2024 | +669,259 | Add 60.53% | 1.78 M | $267.04 |
| Q2 2024 | +75,000 | Add 4.23% | 1.85 M | $280.16 |
| Q3 2024 | +192,000 | Add 10.38% | 2.04 M | $192.27 |
| Q1 2025 | +57,523 | Add 2.82% | 2.1 M | $331.23 |
| Q2 2025 | -10,000 | Reduce 0.48% | 2.09 M | $302.64 |
| Q3 2025 | -182,000 | Reduce 8.71% | 1.91 M | $458.66 |
John Paulson's Madrigal Pharmaceuticals Investment FAQs
John Paulson first purchased Madrigal Pharmaceuticals, Inc. (MDGL) in Q2 2023, acquiring 350,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Paulson has held Madrigal Pharmaceuticals, Inc. (MDGL) for 10 quarters since Q2 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Paulson's largest addition to Madrigal Pharmaceuticals, Inc. (MDGL) was in Q1 2024, adding 1,775,000 shares worth $474 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, John Paulson's firm, Paulson & Co. Inc., owns 1,907,523 shares of Madrigal Pharmaceuticals, Inc. (MDGL), valued at approximately $874.9 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Madrigal Pharmaceuticals, Inc. (MDGL) represents approximately 29.46% of John Paulson's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Paulson's peak holding in Madrigal Pharmaceuticals, Inc. (MDGL) was 2,099,523 shares, as reported at the end of Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.